JP2015520184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520184A5 JP2015520184A5 JP2015515646A JP2015515646A JP2015520184A5 JP 2015520184 A5 JP2015520184 A5 JP 2015520184A5 JP 2015515646 A JP2015515646 A JP 2015515646A JP 2015515646 A JP2015515646 A JP 2015515646A JP 2015520184 A5 JP2015520184 A5 JP 2015520184A5
- Authority
- JP
- Japan
- Prior art keywords
- oxm
- mal
- lys
- fms
- fmoc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102400000319 Oxyntomodulin Human genes 0.000 claims 44
- 101800001388 Oxyntomodulin Proteins 0.000 claims 44
- 238000000034 method Methods 0.000 claims 31
- 239000011347 resin Substances 0.000 claims 25
- 229920005989 resin Polymers 0.000 claims 25
- PXZWGQLGAKCNKD-DPNMSELWSA-N molport-023-276-326 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 PXZWGQLGAKCNKD-DPNMSELWSA-N 0.000 claims 19
- 125000006239 protecting group Chemical group 0.000 claims 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 7
- 229920000642 polymer Polymers 0.000 claims 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 6
- JLPNPVIABCLANH-UHFFFAOYSA-N 9-[(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxymethyl]-7-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]-9h-fluorene-2-sulfonic acid Chemical compound C=1C(S(=O)(=O)O)=CC=C(C2=CC=C(NC(=O)CCN3C(C=CC3=O)=O)C=C22)C=1C2COC(=O)ON1C(=O)CCC1=O JLPNPVIABCLANH-UHFFFAOYSA-N 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 0 *C(*)NC(OCC1c2cc(NC(CCN(C(CC3S*)=O)C3=O)=*)ccc2-c2ccccc12)=O Chemical compound *C(*)NC(OCC1c2cc(NC(CCN(C(CC3S*)=O)C3=O)=*)ccc2-c2ccccc12)=O 0.000 description 1
- FTIFNUDLFYHCBW-UHFFFAOYSA-N O=C(CCN(C(C=C1)=O)C1=O)Nc1ccc2-c3ccccc3C(COC(ON(C(CC3)=O)C3=O)=O)c2c1 Chemical compound O=C(CCN(C(C=C1)=O)C1=O)Nc1ccc2-c3ccccc3C(COC(ON(C(CC3)=O)C3=O)=O)c2c1 FTIFNUDLFYHCBW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261655367P | 2012-06-04 | 2012-06-04 | |
| US61/655,367 | 2012-06-04 | ||
| PCT/IL2013/050481 WO2013183052A1 (en) | 2012-06-04 | 2013-06-04 | Pegylated oxm variants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018020172A Division JP6549741B2 (ja) | 2012-06-04 | 2018-02-07 | ペグ化oxm変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520184A JP2015520184A (ja) | 2015-07-16 |
| JP2015520184A5 true JP2015520184A5 (enExample) | 2016-07-21 |
| JP6290193B2 JP6290193B2 (ja) | 2018-03-07 |
Family
ID=49711501
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515646A Active JP6290193B2 (ja) | 2012-06-04 | 2013-06-04 | ペグ化oxm変異体 |
| JP2018020172A Active JP6549741B2 (ja) | 2012-06-04 | 2018-02-07 | ペグ化oxm変異体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018020172A Active JP6549741B2 (ja) | 2012-06-04 | 2018-02-07 | ペグ化oxm変異体 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10537646B2 (enExample) |
| EP (1) | EP2854838B1 (enExample) |
| JP (2) | JP6290193B2 (enExample) |
| KR (1) | KR102092025B1 (enExample) |
| CN (2) | CN109096387B (enExample) |
| AU (2) | AU2013273135B2 (enExample) |
| CA (1) | CA2875599C (enExample) |
| CL (1) | CL2014003307A1 (enExample) |
| CO (1) | CO7160097A2 (enExample) |
| EA (1) | EA201492269A1 (enExample) |
| HK (1) | HK1209045A1 (enExample) |
| IL (1) | IL236034B (enExample) |
| IN (1) | IN2015DN00003A (enExample) |
| MX (1) | MX362432B (enExample) |
| PE (1) | PE20150181A1 (enExample) |
| SG (2) | SG10201702228QA (enExample) |
| WO (1) | WO2013183052A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
| US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
| US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US9458444B2 (en) | 2006-02-03 | 2016-10-04 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US12203113B2 (en) | 2009-07-09 | 2025-01-21 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
| US10166295B2 (en) | 2011-06-02 | 2019-01-01 | Opko Biologics Ltd. | Pegylated OXM variants |
| US9522945B2 (en) | 2012-04-19 | 2016-12-20 | Opko Biologics Ltd. | Long-acting oxyntomodulin variants and methods of producing same |
| EA201492269A1 (ru) | 2012-06-04 | 2016-02-29 | Опко Байолоджикс Лтд. | Пегилированные варианты oxm |
| HUE055348T2 (hu) | 2012-11-20 | 2021-11-29 | Opko Biologics Ltd | Eljárás polipeptidek hidrodinamikus térfogatának növelésére gonadotropin karboxil-terminális peptidekhez való kapcsolással |
| US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
| CN104926934B (zh) * | 2014-09-23 | 2016-11-09 | 蒋先兴 | 胃泌酸调节素类似物 |
| PH12021552108A1 (en) | 2014-12-10 | 2022-05-11 | Opko Biologics Ltd | Methods of producing long acting ctp-modified growth hormone polypeptides |
| KR20180014754A (ko) * | 2015-05-29 | 2018-02-09 | 옵코 바이오로직스 리미티드 | 페길화된 옥신토모둘린 변이체 |
| EP3988113A1 (en) | 2015-06-19 | 2022-04-27 | OPKO Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| WO2017075583A2 (en) * | 2015-10-30 | 2017-05-04 | The Research Foundation For The State University Of New York | Oxyntomodulin analogs and methods of making and using same |
| CN113546159B (zh) * | 2015-12-29 | 2023-09-08 | 派格生物医药(苏州)股份有限公司 | 包含glp-1受体激动剂和胰高血糖素受体激动剂的组合物及其用途 |
| EP3468610A1 (en) * | 2016-06-09 | 2019-04-17 | OPKO Biologics Ltd. | Long-acting oxyntomodulin formulation and methods of producing and administering same |
| CN109563145B (zh) | 2016-07-11 | 2024-01-26 | Opko生物科学有限公司 | 长效凝血因子及其制备方法 |
| CN108299554B (zh) * | 2017-01-13 | 2021-05-25 | 博瑞生物医药(苏州)股份有限公司 | 胃泌酸调节素类似物 |
| AU2018318672B2 (en) * | 2017-08-16 | 2021-04-15 | Dong-A St Co., Ltd. | Acylated oxyntomodulin peptide analog |
| US12441776B2 (en) | 2018-11-30 | 2025-10-14 | Eirgen Pharma Ltd. | Oxyntomodulin peptide analog formulations |
| CN113710692A (zh) | 2019-02-11 | 2021-11-26 | Opko生物科学有限公司 | 长效glp-2类似物 |
| WO2025184364A1 (en) * | 2024-03-01 | 2025-09-04 | University Of Notre Dame Du Lac | Self-assembling depots of adjuvant peptide therapies |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| DE3421468A1 (de) | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| ATE110571T1 (de) | 1988-05-06 | 1994-09-15 | Toray Industries | Stabile interferon-beta-zusammensetzung. |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| JP3148298B2 (ja) | 1991-09-02 | 2001-03-19 | 帝人株式会社 | 軽量複合成形物の製造法 |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5541110A (en) | 1994-05-17 | 1996-07-30 | Bristol-Myers Squibb | Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
| CA2204645A1 (en) | 1994-11-07 | 1996-05-17 | Keiichi Yano | Novel oxyntomodulin |
| CN1087317C (zh) | 1995-08-10 | 2002-07-10 | 片冈一则 | 在两末端具有官能基的嵌段聚合物 |
| IL119029A0 (en) | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
| JP2002512982A (ja) | 1998-04-28 | 2002-05-08 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | Peg−lhrhアナログ複合体 |
| US6617276B1 (en) | 2000-07-21 | 2003-09-09 | Johnson Matthey Public Limited Company | Hydrocarbon trap/catalyst for reducing cold-start emissions from internal combustion engines |
| IL139400A0 (en) | 2000-11-01 | 2001-11-25 | Yeda Res & Dev | Long-acting cytokine derivatives and pharmaceutical compositions comprising them |
| EP2123293A3 (en) | 2000-12-14 | 2010-09-08 | Amylin Pharmaceuticals, Inc. | Peptide YY and petide YY agonists for treatment of metabolic disorders |
| GB0121709D0 (en) | 2001-09-07 | 2001-10-31 | Imp College Innovations Ltd | Food inhibition agent |
| KR100870013B1 (ko) | 2002-08-27 | 2008-11-21 | 삼성전자주식회사 | 박막 트랜지스터 어레이 기판 및 그 제조 방법 |
| GB0300571D0 (en) | 2003-01-10 | 2003-02-12 | Imp College Innovations Ltd | Modification of feeding behaviour |
| EP1620118B1 (en) * | 2003-04-08 | 2014-06-18 | Yeda Research And Development Co., Ltd. | Reversible pegylated drugs |
| KR101135244B1 (ko) * | 2007-11-29 | 2012-04-24 | 한미사이언스 주식회사 | 인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물 |
| PT1891105E (pt) * | 2005-06-13 | 2012-06-27 | Imp Innovations Ltd | Análogos de oxintomodulina e seus efeitos sobre o comportamento da alimentação |
| GB0511986D0 (en) * | 2005-06-13 | 2005-07-20 | Imp College Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| US7928058B2 (en) | 2006-02-22 | 2011-04-19 | Merck Sharp & Dohme Corp. | Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition |
| TWM345876U (en) | 2008-06-17 | 2008-12-01 | Yong-Xuan Ji | Auxiliary device for mobile engine |
| EP2350118B1 (en) * | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| JP5759976B2 (ja) | 2009-03-20 | 2015-08-05 | ハンミ・サイエンス・カンパニー・リミテッド | 位置特異的な生理活性ポリペプチド結合体の調製方法 |
| AR079344A1 (es) | 2009-12-22 | 2012-01-18 | Lilly Co Eli | Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad |
| AR079345A1 (es) | 2009-12-22 | 2012-01-18 | Lilly Co Eli | Analogo peptidico de oxintomodulina |
| EP2668286A4 (en) | 2011-01-24 | 2015-07-01 | Univ Ben Gurion | METHOD FOR EVALUATING A MENTAL DISEASE |
| SG10201606243YA (en) * | 2011-06-02 | 2016-09-29 | Prolor Biotech Inc | Long-acting glp-1/glucagon receptor agonists |
| US10166295B2 (en) | 2011-06-02 | 2019-01-01 | Opko Biologics Ltd. | Pegylated OXM variants |
| KR101577734B1 (ko) | 2011-06-17 | 2015-12-29 | 한미사이언스 주식회사 | 옥신토모듈린과 면역글로불린 단편을 포함하는 결합체 및 그의 용도 |
| US9522945B2 (en) | 2012-04-19 | 2016-12-20 | Opko Biologics Ltd. | Long-acting oxyntomodulin variants and methods of producing same |
| EA201492269A1 (ru) | 2012-06-04 | 2016-02-29 | Опко Байолоджикс Лтд. | Пегилированные варианты oxm |
-
2013
- 2013-06-04 EA EA201492269A patent/EA201492269A1/ru unknown
- 2013-06-04 CN CN201811001898.9A patent/CN109096387B/zh active Active
- 2013-06-04 HK HK15109770.0A patent/HK1209045A1/xx unknown
- 2013-06-04 WO PCT/IL2013/050481 patent/WO2013183052A1/en not_active Ceased
- 2013-06-04 CN CN201380040700.7A patent/CN104684576B/zh active Active
- 2013-06-04 CA CA2875599A patent/CA2875599C/en active Active
- 2013-06-04 EP EP13800444.5A patent/EP2854838B1/en active Active
- 2013-06-04 US US14/405,597 patent/US10537646B2/en active Active
- 2013-06-04 PE PE2014002372A patent/PE20150181A1/es not_active Application Discontinuation
- 2013-06-04 SG SG10201702228QA patent/SG10201702228QA/en unknown
- 2013-06-04 IN IN3DEN2015 patent/IN2015DN00003A/en unknown
- 2013-06-04 SG SG11201408054RA patent/SG11201408054RA/en unknown
- 2013-06-04 KR KR1020147037080A patent/KR102092025B1/ko active Active
- 2013-06-04 JP JP2015515646A patent/JP6290193B2/ja active Active
- 2013-06-04 AU AU2013273135A patent/AU2013273135B2/en active Active
- 2013-06-04 MX MX2014014890A patent/MX362432B/es active IP Right Grant
-
2014
- 2014-12-02 IL IL236034A patent/IL236034B/en active IP Right Grant
- 2014-12-03 CL CL2014003307A patent/CL2014003307A1/es unknown
- 2014-12-26 CO CO14284184A patent/CO7160097A2/es unknown
-
2015
- 2015-01-08 US US14/592,641 patent/US9821070B2/en active Active
-
2017
- 2017-11-02 US US15/801,554 patent/US20180050113A1/en not_active Abandoned
-
2018
- 2018-02-07 JP JP2018020172A patent/JP6549741B2/ja active Active
- 2018-03-06 AU AU2018201623A patent/AU2018201623B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520184A5 (enExample) | ||
| Leichner et al. | Thiolated polymers: Bioinspired polymers utilizing one of the most important bridging structures in nature | |
| JP2015110654A5 (enExample) | ||
| JP2011522839A5 (enExample) | ||
| JP2019043957A5 (enExample) | ||
| JP2015536943A5 (enExample) | ||
| JP2011511076A5 (enExample) | ||
| JP2016513638A5 (enExample) | ||
| JP2016153410A5 (enExample) | ||
| JP2014521684A5 (enExample) | ||
| JP2008195730A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| CY1117603T1 (el) | Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2 | |
| JP2014129395A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2008533007A5 (enExample) | ||
| JP2011500814A5 (enExample) | ||
| RU2015146614A (ru) | Конъюгированная вакцина на основе пептида антигена wt1 | |
| JP2008508859A5 (enExample) | ||
| JP2014514365A5 (enExample) | ||
| JP2016509011A5 (enExample) | ||
| JP2014533241A5 (enExample) | ||
| JP2013510169A5 (enExample) | ||
| JP2019513752A5 (enExample) | ||
| RU2013120135A (ru) | Глюкозозависимые инсулинотропные пептидные аналоги |